New oral disease-modifying therapies for multiple sclerosis.
Several promising, oral disease-modifying therapies for multiple sclerosis are currently being evaluated in clinical trials. The arrival of effective oral agents for multiple sclerosis will be a major advance in the global effort to alter the natural history of this chronic disease.
Bridget A
BA
Bagert
Dennis
D
Bourdette